Clinical Trial

Global Utilization And Registry Database for Improved preservAtion of doNor Pancreata (GUARDIAN-PANCREAS)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to collect real-world clinical performance data to assess the clinical outcomes of patients receiving pancreas transplants using donor pancreata transported via the PancreasPak system. These results will be compared to standard of care outcomes, as well as other preservation methods.
Trial Details
NCT Number NCT07487194
Lead Sponsor Paragonix Technologies
Conditions Pancreas (Including SPK) Transplantation, Pancreas Diseases, Pancreas Transplant Rejection, Pancreas Transplant; Complications
Enrollment 1,000 participants
Start Date 2026-06
Primary Completion 2031-06 (estimated)
Study Completion 2032-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-23